These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 3139878)
1. Do gold drugs inhibit interleukin-1? Evidence from an in vitro lymphocyte activating factor assay. Haynes DR; Garrett IR; Whitehouse MW; Vernon-Roberts B J Rheumatol; 1988; 15(5):775-8. PubMed ID: 3139878 [TBL] [Abstract][Full Text] [Related]
2. Synergistic inhibition of T cell proliferation by gold sodium thiomalate and auranofin. Hashimoto K; Whitehurst CE; Lipsky PE J Rheumatol; 1994 Jun; 21(6):1020-6. PubMed ID: 7932408 [TBL] [Abstract][Full Text] [Related]
3. Effects of antirheumatic gold salts on cytokine-induced neutrophil-dependent cytotoxicity for human endothelial cells. Bratt J; Palmblad J J Investig Med; 2000 Nov; 48(6):395-402. PubMed ID: 11094861 [TBL] [Abstract][Full Text] [Related]
4. Mechanisms of action of auranofin: effects on humoral immune response. Walz DT; Dimartino MJ; Griswold DE J Rheumatol Suppl; 1982; 8():32-6. PubMed ID: 6813489 [TBL] [Abstract][Full Text] [Related]
5. Immunopharmacology of auranofin and gold sodium thiomalate: effects on humoral immunity. Walz DT; DiMartino MJ; Griswold DE J Rheumatol Suppl; 1979; 5():74-81. PubMed ID: 114651 [TBL] [Abstract][Full Text] [Related]
6. Distribution of gold in rat blood after intravenous administration of auranofin, gold sodium thiomalate and aurothioglucose to rats. Walz DT; Griswold DE; DiMartino MJ; Bumbier EE J Rheumatol; 1983 Feb; 10(1):117-20. PubMed ID: 6405031 [TBL] [Abstract][Full Text] [Related]
7. The effects of auranofin and gold sodium aurothiomalate on the chemiluminescent response of stimulated synovial tissue cells from patients with rheumatoid arthritis. Harth M; McCain GA; Orange JF J Rheumatol; 1985 Oct; 12(5):881-4. PubMed ID: 3936929 [TBL] [Abstract][Full Text] [Related]
8. Auranofin, gold thiomalate, and gold thioglucose inhibit protein kinase C. Mahoney CW; Hensey CE; Azzi A Biochem Pharmacol; 1989 Oct; 38(19):3383-6. PubMed ID: 2510733 [No Abstract] [Full Text] [Related]
9. Unique properties of auranofin as a potential anti-rheumatic drug. Barrett ML; Lewis GP Agents Actions; 1986 Oct; 19(1-2):109-15. PubMed ID: 3099556 [TBL] [Abstract][Full Text] [Related]
10. Synergistic inhibition of human B cell activation by gold sodium thiomalate and auranofin. Hirohata S; Nakanishi K; Yanagida T; Kawai M; Kikuchi H; Isshi K Clin Immunol; 1999 May; 91(2):226-33. PubMed ID: 10227815 [TBL] [Abstract][Full Text] [Related]
11. The effect of longterm treatment with auranofin and gold sodium thiomalate on immune function in the dog. Bloom JC; Thiem PA; Halper LK; Saunders LZ; Morgan DG J Rheumatol; 1988 Mar; 15(3):409-17. PubMed ID: 3132555 [TBL] [Abstract][Full Text] [Related]
12. Effect of auranofin and sodium aurothiomalate on interleukin-1 production from human monocytes in vitro. Remvig L; Enk C; Bligaard N Scand J Rheumatol; 1988; 17(4):255-62. PubMed ID: 3142038 [TBL] [Abstract][Full Text] [Related]
13. Correlation of in vitro and in vivo effects of gold compounds on leukocyte function: possible mechanisms of action. Wolach B; DeBoard JE; Coates TD; Baehner RL; Boxer LA J Lab Clin Med; 1982 Jul; 100(1):37-44. PubMed ID: 6283001 [TBL] [Abstract][Full Text] [Related]
14. The in vitro effect of gold complexes on bone resorption. Katz JM; Gray DH J Orthop Res; 1986; 4(2):188-93. PubMed ID: 3086527 [TBL] [Abstract][Full Text] [Related]
15. Effects of chrysotherapy on cell mediated immune response. Lorber A; Jackson WH; Simon TM J Rheumatol Suppl; 1982; 8():37-45. PubMed ID: 6813490 [TBL] [Abstract][Full Text] [Related]
16. Latent human leukocyte collagenase can be activated by gold thioglucose and gold sodium thiomalate, but not by auranofin. Sorsa T; Suomalainen K; Turto H; Lindy S Biosci Rep; 1987 Dec; 7(12):965-8. PubMed ID: 2840130 [TBL] [Abstract][Full Text] [Related]
18. Modulation of macrophage-lymphocyte interactions by the antiarthritic gold compound, auranofin. Griswold DE; Lee JC; Poste G; Hanna N J Rheumatol; 1985 Jun; 12(3):490-7. PubMed ID: 2931519 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of TPA-induced NF-kappaB nuclear translocation and production of NO and PGE2 by the anti-rheumatic gold compounds. Yamashita M; Ashino S; Oshima Y; Kawamura S; Ohuchi K; Takayanagi M J Pharm Pharmacol; 2003 Feb; 55(2):245-51. PubMed ID: 12631417 [TBL] [Abstract][Full Text] [Related]
20. [Effects of slow-acting antirheumatic drugs on blast formation of normal lymphocytes]. Hamai T; Negishi M; Takahashi T Ryumachi; 1983 Aug; 23(4):193-201. PubMed ID: 6420896 [No Abstract] [Full Text] [Related] [Next] [New Search]